2020 Nov BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자 Comparison of Myeloablative (CyTBI, BuCy) versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Pretransplant Low WT1 Expression
2020 Oct EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자 Non-myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies
2020 Oct JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 교신저자 Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia
2020 Oct HLA 공동저자 Specific donor HLA allotypes as predictors of cytomegalovirus disease risk in acute myeloid leukemia
2020 Sep NATURE COMMUNICATIONS 공동저자 The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells
2020 Aug LEUKEMIA 공동저자 Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study
2020 Jul FRONTIERS IN ONCOLOGY 교신저자 Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic Option
2020 Jul SENSORS AND ACTUATORS B-CHEMICAL 공동저자 Fluorometric detection of single-nucleotide mutations using tandem gene amplification
2020 Jul BRITISH JOURNAL OF HAEMATOLOGY 교신저자 Successful prevention and screening strategies for COVID-19: focus on patients with haematologic diseases
2020 May CLINICAL EPIGENETICS 공동저자 Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells
2020 May ANNALS OF HEMATOLOGY 공동저자 Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death
2020 Apr LEUKEMIA 공동저자 European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
2020 Apr BRITISH JOURNAL OF HAEMATOLOGY 교신저자 Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)
2020 Mar ANNALS OF HEMATOLOGY 공동저자 Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment
2020 Mar INTERNATIONAL JOURNAL OF HEMATOLOGY 교신저자 Comprehensive analyses of safety and efficacy toward individualizing imatinib dosage in patients with chronic myeloid leukemia
2020 Feb CELL DEATH & DISEASE 공동저자 Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia
2019 Dec NEW ENGLAND JOURNAL OF MEDICINE 교신저자 Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
2019 Dec AUTOPHAGY 교신저자 GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia
2019 Dec New England Journal of Medicine(NEJM / IF=70.670) 교신저자 Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
2019 Dec CANCER MEDICINE 공동저자 Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome?negative acute lymphoblastic leukemia in first salvage
2019 Nov INTERNATIONAL JOURNAL OF HEMATOLOGY 공동저자 A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation
2019 Oct CANCER CELL 공동저자 Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
2019 Oct BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자 Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease
2019 Oct DIGESTIVE DISEASES AND SCIENCES 공동저자 Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B
2019 Oct BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자 WT1 measurable residual disease assay in patients with acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation: Optimal Time Points, Thersholds, and Candidates
2019 Sep HAEMATOLOGICA 공동저자 De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways
2019 Aug LEUKEMIA 공동저자 Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
2019 Jul CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 교신저자 Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid Leukemia
2019 Jun JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 공동저자 Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia
2019 Mar CANCER 공동저자 Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia
2019 Feb JOURNAL FOR IMMUNOTHERAPY OF CANCER 공동저자 Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation
2019 Jan LEUKEMIA RESEARCH 교신저자 Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia
2018 Dec CANCER LETTERS 공동저자 Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release
2018 Nov ANNALS OF HEMATOLOGY 공동저자 Low frequency of CD3(+)CD4(+)CD161(+) T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment
2018 Nov AMERICAN JOURNAL OF HEMATOLOGY 공동저자 Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose
2018 Oct CANCER MEDICINE 교신저자 BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
2018 Oct MEDICINE 공동저자 Cutaneous comorbidities in patients with multiple myeloma: A 10-year retrospective cohort study from a Korean population
2018 Oct BONE MARROW TRANSPLANTATION 공동저자 Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia
2018 Oct CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 교신저자 Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia
2018 Sep BLOOD CANCER JOURNAL 공동저자 Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib
2018 Aug ANNALS OF HEMATOLOGY 교신저자 Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study
2018 Aug EUROPEAN JOURNAL OF HAEMATOLOGY 공동저자 Comparison of transplant-specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndrome
2018 Aug BLOOD 공동저자 Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
2018 Aug HAEMATOLOGICA 공동저자 Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
2018 Aug BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자 Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults
2018 Jul BLOOD 공동저자 Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial
2018 Jun INFECTION AND CHEMOTHERAPY 공동저자 Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review
2018 Jun BLOOD RESEARCH(구 대한혈액학회지/2013년 이후 게재) 공동저자 Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents
2018 May CANCER MEDICINE 교신저자 Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia
2018 Apr ANNALS OF INTERNAL MEDICINE 공동저자 Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study
2018 Apr CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 공동저자 Prognostic Prediction Model for Second Allogeneic Stem-Cell Transplantation in Patients With Relapsed Acute Myeloid Leukemia: Single-Center Report
2018 Mar JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 공동저자 Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea
2018 Jan ONCOTARGET 공동저자 Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy
2018 Jan BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 공동저자 Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells Correlate with Early Infections and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation
2018 Jan LEUKEMIA & LYMPHOMA 교신저자 Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy
2018 Jan BIOMED RESEARCH INTERNATIONAL 공동저자 Circulating CD3+CD4+CD161+ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma
2018 Jan JOURNAL OF CLINICAL ONCOLOGY 공동저자 Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
2017 Dec Clinical Cancer Research 교신저자 Phase III clinical trial (RERISE study) results of Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia.
2017 Aug Cancer 공동저자 Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
2017 Aug 대한면역학회 공동저자 Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma
2017 Jul Leukemia 교신저자 Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.
2017 Jun Oncotarget 공동저자 Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types.
2017 May Clinica Chimica Acta 공동저자 Practical informativeness of short tandem repeat loci for chimerism analysis in hematopoietic stem cell transplantation.
2017 Apr Biology of Blood and Marrow Transplantation 공동저자 Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
2017 Mar PLoS One 공동저자 The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population.
2017 Feb Transplant Infectious Disease 공동저자 Clinical significance of pre-transplant circulating CD3+ CD4+ CD161+ cell frequency on the occurrence of neutropenic infections after allogeneic stem cell transplantation.
2017 Feb Oncotarget 공동저자 Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts
2017 Jan Journal of Hematology & Oncology 공동저자 High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.
2017 Jan Clinical Lymphoma Myeloma and Leukemia 공동저자 Characteristics and Survival Outcome Analysis of Extramedullary Involvement in Adult Patients With t(8;21) Acute Myeloid Leukemia.
2017 Jan Korean journal of internal medicine 교신저자 BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
2017 Jan 대한내과학회 교신저자 BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
2017 Jan Acta Derm Venereol 공동저자 Eruptive Melanocytic Naevi Caused by Radotinib Therapy in Patients with Chronic Myeloid Leukaemia: 10 cases and a literature Review.
저서
2012 Apr 책읽는달 공동 굿바이 암 : 암 치료 패러다임을 뒤집은 표적항암제 10년의 기록
2008 Jun 성우 단독 그림으로 이해하는 만성골수성백혈병
2019 Jul 군자출판사 공동 (Current principles and clinical practice of) internal medicine : 임상진료지침